This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
In the mAb Race, Don’t Stumble at Characterization
Researchers Adapt Existing Techniques to Deal with Challenging New Monoclonal Antibodies
Vertex’s David Altshuler Humanizes Drug Discovery
Lessons from Vertex’s Small Molecule Drug Development Program for Cystic Fibrosis
For full access to this article login to GEN Select now.
Are CMOs Really Going to See a Capacity Pinch?
Serious Capacity Problems for CMOs Seem to Be a Thing of the Past
- A contract manufacturing organization (CMO) with excess production capacity is like a restaurant with unfilled tables—it points to excess overhead, low profitability, and poor planning. Yet full capacity can sometimes be worse in the long run through lost business and permanently unhappy clients. So CMOs balance their capacity to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.